首页> 外文期刊>Synthetic Communications >Synthesis and biological evaluation of 1,2,4-oxadiazole linked 1,3,4-oxadiazole derivatives as tubulin binding agents
【24h】

Synthesis and biological evaluation of 1,2,4-oxadiazole linked 1,3,4-oxadiazole derivatives as tubulin binding agents

机译:1,2,4-氧代唑的合成和生物学评价为1,3,4-二唑衍生物作为小管蛋白结合剂

获取原文
获取原文并翻译 | 示例
           

摘要

As an aspect of our ongoing research in search of new anticancer agents, a series of novel analogs of 1,3,4-oxadiazole embedded with 1,2,4-oxadiazole moieties (11a-j) were synthesized. The structure of the final compounds was confirmed by H-1 NMR, (CNMR)-C-13 and mass spectroscopic techniques and evaluated for their in vitro anticancer activity against three human cancer cell lines (lung, breast). Among the synthesized compounds, 11 b, 11 g, 11 h, and 11i showed potent anticancer activity with IC50 values within the range of 0.34 +/- 0.025 to 2.45 +/- 0.23 mu M against three human cancer cell lines. Further, these compounds (11a-j) were investigated for molecular docking studies. Among them, compound 11 h showed strong binding affinity on binding sites of target protein EGFR (PDB ID: 4hjo) with highest docking score (-7.028). It revealed that 11 h was a strong tubulin binding agent.
机译:作为我们正在进行的研究新的抗癌剂的持续研究的一个方面,嵌入了嵌入1,2,4-氧代唑部分(11A-J)的1,3,4-氧代唑(11A-J)的一系列新种类。 通过H-1 NMR,(CNMR)-C-13和质谱技术证实了最终化合物的结构,并评估其对三种人癌细胞系(肺,乳房)的体外抗癌活性。 在合成化合物中,11b,11g,11h和11i和11i显示出与三种人类癌细胞系的0.34 +/- 0.025至2.45 +/-0.23μm的IC 50值。 此外,研究了这些化合物(11A-J)进行分子对接研究。 其中,化合物11h在具有最高对接得分的靶蛋白EGFR(PDB ID:4HJO)的结合位点具有强烈的结合亲和力(-7.028)。 揭示了11小时是强氧素结合剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号